Table 2 Summary of national average resource-utilisation per administration of a risperidone long-acting injection
Average Resource use | ASGC region: Major Cities (95% CI) | ASGC region: Inner Regional (95% CI) | ASGC region: Outer Regional (95% CI) | ASGC region: Remote & Very Remote (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
   Injection time (min) | 19.4 (19.1 to 19.7) | 18.2 (17.7 to 18.7) | 23.4 (21.8 to 25.1) | 29.0 (27.6 to 30.4) | ||||
   National average injection time (min) |  |  |  |  | 20.12 |  |  | |
Outreach visits | 1 Staff Visits | > 1 Staff Visits | 1 Staff Visits | > 1 Staff Visits | 1 Staff Visits | > 1 Staff Visits | 1 Staff Visits | > 1 Staff Visits |
   Distance travelled/Staff (km) | 22.9 (20.1 to 25.6) | 19.2 (17.2 to 20.1) | 19.4 (18.3 to 20.5) | 19.5 (18. 3 to 23.1) | 66.3 (43.2 to 89.4) | 29.2 (15.5 to 42.9) | 55.5 (12.7 to 98.2) | 218.1 (12.7 to 331.8) |
   Time travelled/Staff (min) | 44.6 (43.0 to 46.3) | 41.4 (38.8 to 44.0) | 34.1 (32.6 to 35.7) | 33.4 (28.4 to 38.4) | 54.4 (40.3 to 68.4) | 29.2 (20.0 to 38.4) | 54.5 (29.6 to 79.3) | 136.3 (70.8 to 201.8) |
   Reduction in outreach visits (%) | 18.0 (0 to 40.3) | 19.6 (0 to 49.6) | 21.2 (0 to 58.1) | 22.5 (0 to 70.9) | 41.7 (4.0 to 79.0) | 38.9 (0 to 100) | 21.4 (0 to 67.6) | 13.3 (0 to 100) |